VCA sells stake of Vetstreet to Schein; Bayer charts mixed results for flea-and-tick portfolio; PetVivo shores up IP;

> VCA ($WOOF) said November 2 that it will sell a majority interest of its subsidiary Vetstreet, a software provider, to Henry Schein ($HSIC) for a recorded gain of $30 million to $35 million. Release

> Bayer announced that sales in its animal health division rose 2% year over year in the third quarter to €357 million ($394 million), helped by growth of its Seresto flea and tick products but hampered by a slight decline in its Advantage product line. Release

> PetVivo Holdings ($PETV) of Minneapolis announced it has been issued a European patent for its mucosal drug-delivery technology, which it is developing for both human and animal health. Release

> AmerisourceBergen ($ABC) announced that revenues in its fiscal fourth quarter grew 12% year over year to $35.5 billion and that its gross profit was up 15% to $1.1 billion, largely due to its acquisition of MWI Veterinary Supply. Release

> Anika Therapeutics ($ANIK), which has a portfolio of products that includes orthopedic therapies for horses, announced that its product revenues grew 8% year over year in the third quarter to $23.7 million and its net income jumped 36% to $8.4 million. Release

> Eli Lilly's ($LLY) Elanco has launched Interceptor Plus, a monthly chicken-flavored chewable tablet for dogs that protects against heartworm caused by Dirofilaria immitis, as well as several intestinal parasites. Release

> Jaguar Animal Health ($JAGX) announced that Cornell University College of Veterinary Medicine has completed a study of Neonorm Calf that supports the drug's ability to optimize the intestinal microbiome in preweaned dairy calves. Release

> France's Vetoquinol announced that its sales in the first 9 months of the year jumped 8.7% to €251.8 million ($277.9 million), thanks largely to a positive currency impact. Release

> Salix animal health expanded its recall of its Good 'n' Fun Beefhide Chicken Sticks dog treats because of possible Salmonella contamination. Release